Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 Jul 2019 07:00 AM
RNS
Phase 1 clinical trial of AGS-v PLUS
31 Jul 2019 07:00 AM
RNS
Finance Director
25 Jul 2019 03:15 PM
RNS
Exercise of Share Options
25 Jul 2019 03:10 PM
RNS
Exercise of Share Options
25 Jul 2019 07:00 AM
RNS
Exercise of Warrants and Issue of Shares
16 Jul 2019 07:00 AM
RNS
Exercise of Share Options
12 Jul 2019 07:00 AM
RNS
Integumen Shares
09 Jul 2019 05:26 PM
RNS
Holding(s) in Company
09 Jul 2019 04:00 PM
RNS
Holding(s) in Company
09 Jul 2019 11:00 AM
RNS
Holding(s) in Company
02 Jul 2019 01:45 PM
RNS
Director's Dealings
28 Jun 2019 07:00 AM
RNS
First Day of Dealings and Re-admission
27 Jun 2019 11:02 AM
RNS
Result of General Meeting
26 Jun 2019 04:10 PM
RNS
Exercise of Share Options
25 Jun 2019 01:24 PM
RNS
Directorate Update
17 Jun 2019 07:00 AM
RNS
RSV Challenge Model Delivers Positive Results
14 Jun 2019 12:13 PM
RNS
Euronext Growth - Schedule One
14 Jun 2019 12:00 PM
RNS
Exercise of Share Options
11 Jun 2019 07:01 AM
RNS
Placing of Shares
11 Jun 2019 07:00 AM
RNS
Audited Final Results
31 May 2019 12:00 PM
RNS
Result of AGM
21 May 2019 07:00 AM
RNS
Exercise of Share Options
10 May 2019 07:01 AM
RNS
Conditional Acquisition of Open Orphan DAC
10 May 2019 07:00 AM
RNS
Preliminary Final Results
01 May 2019 11:00 AM
RNS
Integumen Debt Conversion
26 Apr 2019 09:56 AM
RNS
2018 Annual Report and Financial Statements
11 Apr 2019 07:00 AM
RNS
Preliminary Results 2018
08 Apr 2019 07:00 AM
RNS
Financing Update
01 Apr 2019 01:21 PM
RNS
Director's Dealings
29 Mar 2019 07:00 AM
RNS
hVIVO and Imutex to present at IVW 2019
26 Mar 2019 07:00 AM
RNS
Change of Adviser
21 Mar 2019 10:34 AM
RNS
Exercise of Share Options
08 Mar 2019 07:00 AM
RNS
Notice of Preliminary Results
30 Jan 2019 09:55 AM
RNS
Holding(s) in Company
24 Jan 2019 10:12 AM
RNS
Share Incentive Plan and PDMR Dealings
21 Jan 2019 04:40 PM
RNS
Second Price Monitoring Extn
21 Jan 2019 04:35 PM
RNS
Price Monitoring Extension
18 Jan 2019 07:00 AM
RNS
Partnership Announcement
10 Jan 2019 07:00 AM
RNS
Positive data for Phase IIb FLU-v challenge study
04 Jan 2019 04:00 PM
RNS
Director's Dealings
04 Jan 2019 10:02 AM
RNS
Award of Share Options
02 Jan 2019 07:00 AM
RNS
Directorate Change
24 Dec 2018 12:36 PM
RNS
Price Monitoring Extension
21 Dec 2018 04:29 PM
RNS
Director/PDMR Shareholding
20 Dec 2018 05:04 PM
RNS
Holding(s) in Company
11 Dec 2018 07:00 AM
RNS
Strategic Collaboration Agreement and Financing
20 Nov 2018 07:00 AM
RNS
Exercise of Share Options
08 Nov 2018 10:40 AM
RNS
Trading Update and Change of Adviser
31 Oct 2018 07:00 AM
RNS
Partial preliminary results for NIH study of AGS-v
08 Oct 2018 02:00 PM
RNS
Director's Dealings

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings